Replies to post #269005 on Innovation Pharmaceuticals Inc (IPIX)

[JTORENCE]

George h great move. Hellava lot better than posting "B" is worth 15 billion .

[steelyeye]

Good goin' george, hope IPIX gets a lot more attention as the company successfully develops many of their Brilacidin indications.

This first one, for their smallest market indication (UP/UPS), puts this company on the GI map. Now we need to replicate previous good results, and maybe even better with foam "retention" in the lower colon.

I just sent an email to several staff members of "Endpoints News" a pharma news journal:

I'd like to call to your attention the recent press release of IPIX, Innovation Pharmaceuticals, regarding their deal with the Italian pharma co., Alphasigma:
INNOVATION PHARMACEUTICALS ANNOUNCES LICENSE AGREEMENT WITH ALFASIGMA S.P.A. FOR THE DEVELOPMENT AND COMMERCIALIZATION OF BRILACIDIN IN ULCERATIVE PROCTITIS/ULCERATIVE PROCTOSIGMOIDITIS
Brilacidin is been successful in several studies. I hope you will investigate and report about this promising development.
Disclosure: I am a shareholder of IPIX.
Thanks,
gh